DISQUS

Pharmababble: GlaxoSmithKline Buys Sirtris for $720M

  • razormd · 1 year ago
    ...I absolutely agree that the deal is utter nonsense and probably some some GSK's manager self-promoting idea to keep GSK at the "forefront" of science...the only things really accomplished were some venture capitalists no doubt cleaned up and the odds that we'll all will be paying more for GSK drugs have increased substantially...what's really disgusting is thinking about what 750 million dollars COULD have accomplished for healthcare in third world countries.
  • Skin · 10 months ago
    Would be interested see the updates on this thing, thanks.
  • TheEben · 10 months ago
    As far as I know, there are no updates. No new trials and no change in
    status for preclinical compounds.